Cancer resistance to therapies against the EGFR-RAS-RAF pathway: The role of MEK.

Cancer resistance to therapies against the EGFR-RAS-RAF pathway: The role of MEK.

Item
http://www.wikidata.org/entity/Q39078257
Targeting NRASQ61K mutant delays tumor growth and angiogenesis in non-small cell lung cancerMicroRNA-326 suppresses the proliferation, migration and invasion of cervical cancer cells by targeting ELK1Optimizing drug development in oncology by clinical trial simulation: Why and how?Looking to the metabolic landscapes for prostate health monitoringIL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model.Emerging uses of biomarkers in lung cancer management: molecular mechanisms of resistance.A biomaterial screening approach reveals microenvironmental mechanisms of drug resistance.Targeting tumour microenvironment by tyrosine kinase inhibitor.Mutational Profiling of Malignant Mesothelioma Revealed Potential Therapeutic Targets in EGFR and NRAS.Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery.Targeted Therapy: Attacking Cancer with Molecular and Immunological Targeted Agents.[Research Advances of Pan-negative Type of Non-small Cell Lung Cancer].Phase Ib Results of the Rational Combination of Selumetinib and Cyclosporin A in Advanced Solid Tumors with an Expansion Cohort in Metastatic Colorectal CancerDevelopment of small-molecule therapeutics and strategies for targeting RAF kinase in BRAF-mutant colorectal cancerPrognostic Value of CD44 and Its Isoforms in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis
P2860

Cancer resistance to therapies against the EGFR-RAS-RAF pathway: The role of MEK.

Item
http://www.wikidata.org/entity/Q39078257
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Cancer resistance to therapies against the EGFR-RAS-RAF pathway: The role of MEK.
@en
Cancer resistance to therapies against the EGFR-RAS-RAF pathway: The role of MEK.
@nl
type
label
Cancer resistance to therapies against the EGFR-RAS-RAF pathway: The role of MEK.
@en
Cancer resistance to therapies against the EGFR-RAS-RAF pathway: The role of MEK.
@nl
prefLabel
Cancer resistance to therapies against the EGFR-RAS-RAF pathway: The role of MEK.
@en
Cancer resistance to therapies against the EGFR-RAS-RAF pathway: The role of MEK.
@nl
P1433
P1476
P2093
P304
P31
P356
P478
P50
P577
P698
P356
P1433
P1476
Cancer resistance to therapies against the EGFR-RAS-RAF pathway: The role of MEK.
@en
P2093
P304
P31
P356
10.1016/J.CTRV.2016.12.001
P478
P50
P577
P698